82 related articles for article (PubMed ID: 1856575)
1. Lipoprotein composition and HDL particle size distribution in women with non-insulin-dependent diabetes mellitus and the effects of probucol treatment.
Lane JT; Subbaiah PV; Otto ME; Bagdade JD
J Lab Clin Med; 1991 Aug; 118(2):120-8. PubMed ID: 1856575
[TBL] [Abstract][Full Text] [Related]
2. Effects of glyburide treatment on serum lipoprotein and apolipoprotein concentrations and ratios in non-insulin-dependent diabetes mellitus.
Waysbort J; Regitz G; Brunner D
Clin Ther; 1988; 10(4):392-400. PubMed ID: 3152618
[TBL] [Abstract][Full Text] [Related]
3. Probucol treatment in hypercholesterolemic patients: effects on lipoprotein composition, HDL particle size, and cholesteryl ester transfer.
Bagdade JD; Kaufman D; Ritter MC; Subbaiah PV
Atherosclerosis; 1990 Oct; 84(2-3):145-54. PubMed ID: 2282096
[TBL] [Abstract][Full Text] [Related]
4. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
5. Plasma lipoprotein composition and cholesteryl ester transfer from high density lipoproteins to very low density and low density lipoproteins in patients with non-insulin-dependent diabetes mellitus.
Bhatnagar D; Durrington PN; Kumar S; Mackness MI; Boulton AJ
Diabet Med; 1996 Feb; 13(2):139-44. PubMed ID: 8641118
[TBL] [Abstract][Full Text] [Related]
6. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
Hayashi T; Hirano T; Yamamoto T; Ito Y; Adachi M
Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958
[TBL] [Abstract][Full Text] [Related]
7. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H
Artery; 1993; 20(1):1-18. PubMed ID: 8447724
[TBL] [Abstract][Full Text] [Related]
8. Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus.
Waysbort J; Regitz G; Chaimowitz D; Tuval M; Nakash I; Brunner D
Clin Ther; 1988; 10(4):358-71. PubMed ID: 2978874
[TBL] [Abstract][Full Text] [Related]
9. Improved lipoprotein surface and core lipid composition following intraperitoneal insulin delivery in insulin-dependent diabetes mellitus.
Bagdade JD; Dunn FL
Diabetes Metab; 1996 Dec; 22(6):420-6. PubMed ID: 8985650
[TBL] [Abstract][Full Text] [Related]
10. Relation of high plasma triglyceride levels associated with obesity and regional adipose tissue distribution to plasma lipoprotein-lipid composition in premenopausal women.
Després JP; Moorjani S; Tremblay A; Ferland M; Lupien PJ; Nadeau A; Bouchard C
Clin Invest Med; 1989 Dec; 12(6):374-80. PubMed ID: 2612090
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein changes in children after liver transplantation: mild hypertriglyceridemia and a decrease in HDL3/HDL2 ratio.
Granot E
Hepatology; 1998 Jan; 27(1):175-80. PubMed ID: 9425934
[TBL] [Abstract][Full Text] [Related]
12. Effect of probucol on serum lipoprotein and apoprotein profiles in renal transplant patients.
Okubo M; Horii A; Kamata K; Takeuchi Y; Tsukamoto Y; Kobayashi N; Sato K; Kumano K; Endo T
Am J Kidney Dis; 1998 Feb; 31(2):356-9. PubMed ID: 9469511
[TBL] [Abstract][Full Text] [Related]
13. Persistent abnormalities in lipoprotein composition in noninsulin-dependent diabetes after intensive insulin therapy.
Bagdade JD; Buchanan WE; Kuusi T; Taskinen MR
Arteriosclerosis; 1990; 10(2):232-9. PubMed ID: 2180397
[TBL] [Abstract][Full Text] [Related]
14. Abnormal particle size of lipoprotein in non-insulin-dependent diabetics and nondiabetics with and without hyperlipidemia.
Nakajo Y; Tanaka A; Uchimura I
Bull Tokyo Med Dent Univ; 1991 Dec; 38(4):63-71. PubMed ID: 1764762
[TBL] [Abstract][Full Text] [Related]
15. Effects of probucol and pravastatin on plasma lipids, activities of postheparin lipoprotein lipase, and lecithin cholesterol acyltransferase and apo A-I containing lipoproteins with and without apo A-II in patients with moderate hypercholesterolemia.
Kagami A; Ishikawa T; Tada N; Sakamoto T; Mochizuki K; Nagano M; Moriguchi EH; Manabe M
Clin Biochem; 1993 Apr; 26(2):101-7. PubMed ID: 8485855
[TBL] [Abstract][Full Text] [Related]
16. Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients.
Harada N; Kashiwagi A; Nishio Y; Kikkawa R
Diabetes Res Clin Pract; 1999 Feb; 43(2):111-20. PubMed ID: 10221663
[TBL] [Abstract][Full Text] [Related]
17. Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes.
Laakso M; Pyörälä K
Metabolism; 1990 Feb; 39(2):117-22. PubMed ID: 2299984
[TBL] [Abstract][Full Text] [Related]
18. Effects of tamoxifen treatment on plasma lipids and lipoprotein lipid composition.
Bagdade JD; Wolter J; Subbaiah PV; Ryan W
J Clin Endocrinol Metab; 1990 Apr; 70(4):1132-5. PubMed ID: 2318936
[TBL] [Abstract][Full Text] [Related]
19. Whole-plasma and high-density lipoprotein subfraction surface lipid composition in IDDM men.
Bagdade JD; Subbaiah PV
Diabetes; 1989 Oct; 38(10):1226-30. PubMed ID: 2507376
[TBL] [Abstract][Full Text] [Related]
20. Abnormal cholesterol distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM.
Abate N; Vega GL; Garg A; Grundy SM
Atherosclerosis; 1995 Nov; 118(1):111-22. PubMed ID: 8579621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
